A review on shared genetic architecture of endometriosis and migraine: from pleiotropy to convergent inflammatory pathways - Scorecard - MDSpire

A review on shared genetic architecture of endometriosis and migraine: from pleiotropy to convergent inflammatory pathways

  • By

  • Qian Yang

  • Shengyuan Yu

  • May 15, 2026

  • 0 min

Share

Clinical Scorecard: Exploring the Common Genetic Foundations of Endometriosis and Migraine: Insights into Pleiotropy and Shared Inflammatory Mechanisms

At a Glance

CategoryDetail
ConditionEndometriosis and Migraine Comorbidity
Key MechanismsPleiotropy, Inflammatory Pathways, Central Sensitization
Target PopulationWomen with chronic pain conditions
Care SettingNeurology and Gynecology

Key Highlights

  • Endometriosis increases the likelihood of migraine by up to twofold.
  • Shared genetic loci (e.g., TRIM32, SLC44A4) link endometriosis and migraine.
  • Central sensitization is a key mechanism linking both disorders.
  • Common inflammatory pathways (IL-1, TNF-α, MAPK/ERK) are involved.
  • Genetic stratification may enhance personalized treatment approaches.

Guideline-Based Recommendations

Diagnosis

  • Consider the comorbidity of endometriosis and migraine in patients with chronic pain.

Management

  • Explore treatments targeting shared inflammatory pathways.

Monitoring & Follow-up

  • Monitor for exacerbation of symptoms in patients with both conditions.

Risks

  • Increased pain, disability, and reduced quality of life in comorbid patients.

Patient & Prescribing Data

Women with endometriosis and migraine.

Potential for repurposing treatments based on shared genetic mechanisms.

Clinical Best Practices

  • Integrate care between neurology and gynecology for comorbid patients.
  • Utilize genetic information for personalized treatment strategies.
  • Address central sensitization in management plans.

Related Resources & Content

Original Source(s)

A review on shared genetic architecture of endometriosis and migraine: from pleiotropy to convergent inflammatory pathways

  • by Qian Yang, Shengyuan Yu

  • May 15, 2026

Related Content

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.